LenVat 4 – Lenvatinib Capsules 4 mg In Pakistan

LenVat 4 contains Lenvatinib 4 mg, an oral prescription medicine belonging to the class of tyrosine kinase inhibitors (TKIs). Lenvatinib works by blocking certain signaling pathways involved in the growth of blood vessels that supply tumors, helping to slow or inhibit cancer-cell growth.

Active Ingredient

• Generic Name: Lenvatinib
• Strength: 4 mg
• Dosage Form: Capsules
• Therapeutic Class: Tyrosine Kinase Inhibitor
• Route of Administration: Oral

Uses & Indications

Lenvatinib may be prescribed for certain types of cancer, depending on the patient's diagnosis and treatment plan. Approved uses in different jurisdictions include:

• Differentiated thyroid cancer that is refractory to radioactive iodine therapy
• Certain types of advanced kidney cancer, generally in combination with another anticancer medicine
• Certain advanced endometrial cancers, in combination with pembrolizumab, when appropriate
• Selected cases of unresectable hepatocellular carcinoma, depending on local regulatory approval and treatment guidelines

The approved indications can vary by country and product registration.

How Does Lenvatinib Work?

Lenvatinib inhibits several receptor tyrosine kinases, including pathways involving VEGFR, FGFR, PDGFR-alpha, RET, and KIT. By interfering with these pathways, it can reduce tumor-associated blood-vessel formation and signaling that contributes to tumor growth.

Dosage & Administration

The appropriate dose depends on the type of cancer, treatment combination, liver and kidney function, and individual patient factors. Lenvatinib should be taken exactly as prescribed by an oncologist.

Capsules are generally taken orally and should be swallowed with water. They may be taken with or without food. Do not change the dose or stop treatment without consulting your doctor.

Common Side Effects

Possible side effects include:

• High blood pressure
• Fatigue or weakness
• Diarrhea
• Decreased appetite
• Weight loss
• Nausea or vomiting
• Mouth sores
• Headache
• Joint or muscle pain
• Protein in the urine
• Hand-foot syndrome
• Changes in thyroid function

Serious Side Effects

Lenvatinib can cause serious adverse reactions. Seek immediate medical attention for symptoms such as:

• Severe or uncontrolled high blood pressure
• Chest pain or difficulty breathing
• Severe bleeding
• Signs of blood clots or stroke
• Severe abdominal pain
• Persistent or severe diarrhea
• Significant reduction in urine output
• Severe headache, confusion, or vision changes
• Wound-healing problems

Precautions

Before starting treatment, inform your doctor if you have:

• High blood pressure
• Heart disease
• Liver or kidney problems
• A history of blood clots or bleeding
• Thyroid disorders
• Recent surgery or planned surgery
• A history of gastrointestinal problems

Regular monitoring of blood pressure, kidney function, liver function, thyroid function, and urine protein may be required during treatment.

Drug Interactions

Tell your healthcare professional about all prescription medicines, over-the-counter medicines, vitamins, and supplements you take. Lenvatinib may interact with medicines that affect heart rhythm, blood pressure, kidney function, or bleeding risk.

Pregnancy & Breastfeeding

Lenvatinib may cause fetal harm. Women who can become pregnant should discuss effective contraception with their healthcare provider during treatment and for the recommended period after treatment. Breastfeeding is generally not recommended during treatment and for the recommended period afterward.

Storage

Store LenVat 4 according to the manufacturer's instructions, generally at room temperature, away from excessive heat, moisture, and direct light. Keep out of reach of children.

Important Information

LenVat 4 (Lenvatinib 4 mg) is a prescription anticancer medicine and should only be used under the supervision of a qualified oncologist. The 4 mg strength may be used as part of an individualized dosing regimen, including dose adjustments when required.

Disclaimer: This information is for educational purposes and does not replace advice from a doctor or pharmacist. Always follow the prescribing information supplied with the specific LenVat 4 product available in your country.